NCT04679272View on ClinicalTrials.gov

Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

February 1, 2021

Conditions
Covid19Rheumatoid Arthritis
Trial Locations (1)

34295

UH Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04679272 - Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter